<VariationArchive VariationID="2037024" VariationName="NM_017570.5(OPLAH):c.206_251dup (p.Thr85fs)" VariationType="Duplication" Accession="VCV002037024" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-15" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2097517" VariationID="2037024">
      <GeneList>
        <Gene Symbol="OPLAH" FullName="5-oxoprolinase, ATP-hydrolysing" GeneID="26873" HGNC_ID="HGNC:8149" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144050322" stop="144063961" display_start="144050322" display_stop="144063961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145106166" stop="145115583" display_start="145106166" display_stop="145115583" Strand="-" />
          </Location>
          <OMIM>614243</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_017570.5(OPLAH):c.206_251dup (p.Thr85fs)</Name>
      <CanonicalSPDI>NC_000008.11:144059710:GCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCAGC:GCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCAGCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCAGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144059710" stop="144059711" display_start="144059710" display_stop="144059711" variantLength="46" positionVCF="144059710" referenceAlleleVCF="G" alternateAlleleVCF="GGCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145114613" stop="145114614" display_start="145114613" display_stop="145114614" variantLength="46" positionVCF="145114613" referenceAlleleVCF="G" alternateAlleleVCF="GGCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCA" />
      </Location>
      <ProteinChange>T85fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.145114616_145114661dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.145114616_145114661dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.144059713_144059758dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.144059713_144059758dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032671.1" sequenceAccession="NG_032671" sequenceVersion="1" change="g.5926_5971dup">
            <Expression>NG_032671.1:g.5926_5971dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017570.5" sequenceAccession="NM_017570" sequenceVersion="5" change="c.206_251dup" MANESelect="true">
            <Expression>NM_017570.5:c.206_251dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060040.1" sequenceAccession="NP_060040" sequenceVersion="1" change="p.Thr85fs">
            <Expression>NP_060040.1:p.Thr85fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017570.5(OPLAH):c.206_251dup (p.Thr85fs) AND 5-Oxoprolinase deficiency" Accession="RCV002899584" Version="2">
        <ClassifiedConditionList TraitSetID="7702">
          <ClassifiedCondition DB="MedGen" ID="C0268525">5-Oxoprolinase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21651516</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27477828</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7702" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="109" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Oxoprolinuria due to 5-oxoprolinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">5-alpha-oxoprolinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">5-Oxoprolinase deficiency</ElementValue>
                <XRef ID="5-Oxoprolinase+Deficiency/51" DB="Genetic Alliance" />
                <XRef ID="26132002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPLAHD</ElementValue>
                <XRef Type="MIM" ID="260005" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5681" />
                <XRef ID="5681" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="33572" DB="Orphanet" />
              <XRef ID="C0268525" DB="MedGen" />
              <XRef ID="MONDO:0009825" DB="MONDO" />
              <XRef Type="MIM" ID="260005" DB="OMIM" />
              <XRef Type="primary" ID="HP:0040142" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5931519" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15350325|MedGen:C0268525" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003241728" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21651516</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27477828</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr85Glyfs*51) in the OPLAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OPLAH are known to be pathogenic (PMID: 21651516, 27477828). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with OPLAH-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OPLAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.145114613_145114614insGCCACTGTGGTGCCCATGCGGATGCTGGCGATATGACTGGAGTCCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268525" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5931519" TraitType="Disease" MappingType="XRef" MappingValue="C0268525" MappingRef="MedGen">
        <MedGen CUI="C0268525" Name="5-Oxoprolinase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

